31/07/2018
New Aimovig Medication Approved

Novartis marks a new era for migraine patients with the EU approval of Aimovig®, a first-of-its- kind treatment specifically designed for migraine pr...

Read More

16/07/2018
Why is migraine still a big mystery to science

Very common especially in women, these intense headaches are still a great medical mystery whose causes are not enlightened. Very common especially in...

Read More

18/06/2018
11.3% of Spanish adolescents suffer from migraine headaches

The journal Cephalalgia – the scientific publication of the International Society of Headaches – has just published a study by members of the Head...

Read More

06/06/2018
Why are migraine patients skipping effective behavioral treatments?

Effective behavioral treatments for migraine are being eschewed by a significant number of sufferers, according to a new study led by headache researc...

Read More

06/06/2018
This is how a medicine is manufactured (from the laboratory to the pharmacy)

Ten years and a billion euros. This is the time and average cost for a drug to complete the process that goes from its initial discovery to being sold...

Read More

04/06/2018
How to take care of your diet if you suffer migraine

30 DE MAYO DE 2018 If we pay attention to what we eat, we can contribute to keeping headaches as far away from our lives as possible. If you have migr...

Read More

04/06/2018
Novartis’ Migraine prevention therapy is closer to being approved

Friday, June 1, 2018, at 15:45 Novartis has announced that the European Medicines Agency (EMA) Committee on Human Use Medicines (CHMP) has recommended...

Read More

01/06/2018
First monoclonal antibody therapy for prevention of migraine

First monoclonal antibody therapy for prevention of Migraine Aimovig recommended for marketing authorization 01/06/2018 The European Medicines Agency...

Read More

23/05/2018
Arnold Neuralgia/Recurrent occipital pain cause

Recurrent, troublesome occipital pain associated with muscular tension is known as Arnold's neuralgia, a strange condition. The condition of periphera...

Read More

22/05/2018
A laboratory that takes care of its employees

The following article shows a clear example of best practices at work and how important it is to have employees happy and satisfied at the workspace i...

Read More
New Aimovig Medication Approved
Novartis marks a new era for migraine patients wit...
Why is migraine still a big mystery to science
Very common especially in women, these intense hea...
11.3% of Spanish adolescents suffer from migraine headaches
The journal Cephalalgia – the scientific publica...
Why are migraine patients skipping effective behavioral treatments?
Effective behavioral treatments for migraine are b...
This is how a medicine is manufactured (from the laboratory to the pharmacy)
Ten years and a billion euros. This is the time an...
How to take care of your diet if you suffer migraine
30 DE MAYO DE 2018 If we pay attention to what we...
Novartis’ Migraine prevention therapy is closer to being approved
Friday, June 1, 2018, at 15:45 Novartis has announ...
First monoclonal antibody therapy for prevention of migraine
First monoclonal antibody therapy for prevention o...
Arnold Neuralgia/Recurrent occipital pain cause
Recurrent, troublesome occipital pain associated w...
A laboratory that takes care of its employees
The following article shows a clear example of bes...
Home 2017-07-19T12:26:14+00:00

All EMHA Members

EMHA Calendar

EMHA members at the EPF General Assembly

10/08/2018 Spotted Olivia Serratosa (EMHA past Communication and Social Media expert) and Isabel Colomina (AEPA...

Read More

Brain Awareness week 1

Brain Awareness Week- EBC

start 15/03/2018 09:00

Read More

What is EMHA?

The European Migraine & Headache Alliance is a non-profit, patient umbrella group which was launched in 2006. Since then, the Alliance has grown to represent 25 patient groups from across the continent.

The development of European umbrella organisations is a natural progression with more relevance for European nations.

Read More

About Headache

Headache disorders are among the most common disorders of the nervous system. These include tension-type headache (TTH), migraine and chronic daily headache syndromes as well as the more rare disorders, cluster headache and trigeminal neuralgia.

Read More

datas
EMHA Data charts

Statistical data

In 2010, EHA launched its Madrid Manifesto for Migraine/ Headache Disorders at the Spanish Parliament to mark European Migraine Day of Action. This document outlined our 5-year objectives to improve migraine management, education and awareness across Europe.

Projects

EMHA is the result of the need of making society know the different types of migraine that exist and that currently are not receiving the importance they deserve. EMHA fights for the human rights, that is why is present in activities and events that are relevant for headache issues. Trying to give voice for those ones who need it. EMHA works as well in finding a way to mitigate migraine, by joining forces and strengthening partnerships which are aiming the same objective.

Utilizamos cookies propias y de terceros para el correcto funcionamiento del portal y de sus complementos, reproducir conteido multimeda, interactuar con redes sociales y realizar analíticas de navegación. Si continúas navegando aceptas el uso de dicha tecnología, para más información visita nuestra política de cookies. Find out more

Los ajustes de cookies de esta web están configurados para "permitir cookies" y así ofrecerte la mejor experiencia de navegación posible. Si sigues utilizando esta web sin cambiar tus ajustes de cookies o haces clic en "Aceptar" estarás dando tu consentimiento a esto.

Cerrar